Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
Report an inappropriate content
Please select one of the options below.
  • Length
    AllShort (less than 5 minutes)Medium (5-20 minutes)Long (more than 20 minutes)
  • Date
    AllPast 24 hoursPast weekPast monthPast year
  • Resolution
    AllLower than 360p360p or higher480p or higher720p or higher1080p or higher
  • Source
    All
    Dailymotion
    Vimeo
    Metacafe
    Hulu
    VEVO
    Myspace
    MTV
    CBS
    Fox
    CNN
    MSN
  • Price
    AllFreePaid
  • Clear filters
  • SafeSearch:
  • Moderate
    StrictModerate (default)Off
Filter
Medline discussing upsizing IPO, unlikely to price at high end: Source
1:24
Medline discussing upsizing IPO, unlikely to price at high end: Source
2 weeks ago
MSNCNBC
Medline's IPO was the largest we've seen in over four years, says Jim Cramer
1:41
Medline's IPO was the largest we've seen in over four years, says Jim …
2 weeks ago
MSNCNBC
Medline poised as largest 2025 IPO globally
2:00
Medline poised as largest 2025 IPO globally
2 weeks ago
MSNCNBC
Why Medline may be a key test for the IPO market
3:48
Why Medline may be a key test for the IPO market
2 weeks ago
MSNCNBC
Medline opens at $35, above IPO price of $29
1:48
Medline opens at $35, above IPO price of $29
2 weeks ago
MSNCNBC
Medline CEO on IPO: This is the right time for us to expand our voice
4:30
Medline CEO on IPO: This is the right time for us to expand our voice
2 weeks ago
MSNCNBC
Medline discussing upsizing IPO, unlikely to price at high end: Source
1:24
Medline discussing upsizing IPO, unlikely to price at high end: Source
2 weeks ago
CNBC
2:01
Boring companies are going public again, strong signal for 2026 IPOs…
2 weeks ago
MSNCNBC
3:48
Why Medline may be a key test for the IPO market
2 weeks ago
CNBC
5:07
This is going to be the ‘story for market’ for rest of year, says Ben …
2 weeks ago
MSNFox Business
See more videos
Static thumbnail place holder
More like this
Feedback
  • Privacy
  • Terms